Literature DB >> 27784698

Remnant Cholesterol and Triglyceride-Rich Lipoproteins in Atherosclerosis Progression and Cardiovascular Disease.

Anette Varbo1, Børge G Nordestgaard2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27784698     DOI： 10.1161/ATVBAHA.116.308305

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  23 in total

1.  ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model.

Authors:  Eva Hurt-Camejo
Journal:  J Lipid Res       Date:  2020-01-24       Impact factor: 5.922

2.  Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

Authors:  Anum Saeed; Elena V Feofanova; Bing Yu; Wensheng Sun; Salim S Virani; Vijay Nambi; Josef Coresh; Cameron S Guild; Eric Boerwinkle; Christie M Ballantyne; Ron C Hoogeveen
Journal:  J Am Coll Cardiol       Date:  2018-07-10       Impact factor: 24.094

3.  Remnant cholesterol for the detection of glucose metabolic states in patients with coronary heart disease angina pectoris.

Authors:  Yang Wang; Yijia Liu; Rongrong Yang; Zhu Li; Jinyu Su; Tong Yang; Mei Ma; Guangwei Pan; Xianliang Wang; Lin Li; Chunquan Yu
Journal:  Acta Diabetol       Date:  2022-07-23       Impact factor: 4.087

Review 4.  Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.

Authors:  Bai-Hui Zhang; Fan Yin; Ya-Nan Qiao; Shou-Dong Guo
Journal:  Front Mol Biosci       Date:  2022-05-25

Review 5.  Cardiovascular Immunotherapy and the Role of Imaging.

Authors:  Eva Zupančič; Zahi A Fayad; Willem J M Mulder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11       Impact factor: 8.311

6.  Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.

Authors:  Stephanie T Chung; Celeste K L Cravalho; Abby G Meyers; Amber B Courville; Shanna Yang; Nirupa Rachel Matthan; Lilian Mabundo; Maureen Sampson; Ronald Ouwerkerk; Ahmed M Gharib; Alice H Lichtenstein; Alan T Remaley; Anne E Sumner
Journal:  Circ Res       Date:  2019-10-18       Impact factor: 17.367

7.  Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density Lipoproteins.

Authors:  Patrick R Lawler; Akintunde O Akinkuolie; Paulo Harada; Robert J Glynn; Daniel I Chasman; Paul M Ridker; Samia Mora
Journal:  J Am Heart Assoc       Date:  2017-12-09       Impact factor: 5.501

8.  Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.

Authors:  Patrick R Lawler; Akintunde O Akinkuolie; Audrey Y Chu; Svati H Shah; William E Kraus; Damian Craig; Latha Padmanabhan; Robert J Glynn; Paul M Ridker; Daniel I Chasman; Samia Mora
Journal:  J Am Heart Assoc       Date:  2017-07-21       Impact factor: 5.501

Review 9.  Genetics of Triglycerides and the Risk of Atherosclerosis.

Authors:  Jacqueline S Dron; Robert A Hegele
Journal:  Curr Atheroscler Rep       Date:  2017-07       Impact factor: 5.113

Review 10.  Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies.

Authors:  Hayato Tada; Atsushi Nohara; Masa-Aki Kawashiri
Journal:  Nutrients       Date:  2018-11-17       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.